Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $27.6 Million - $32.7 Million
-593,080 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $1.52 Million - $1.88 Million
33,137 Added 5.92%
593,080 $30.7 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $1.68 Million - $2.49 Million
40,672 Added 7.83%
559,943 $33.1 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $715,370 - $918,954
-18,226 Reduced 3.39%
519,271 $22.3 Million
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $522,131 - $591,487
14,540 Added 2.78%
537,497 $21 Million
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $34,930 - $39,394
-1,043 Reduced 0.2%
522,957 $18.9 Million
Q4 2020

Feb 01, 2021

BUY
$33.47 - $42.56 $1.62 Million - $2.06 Million
48,396 Added 10.18%
524,000 $19.3 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $6.94 Million - $8.14 Million
218,506 Added 84.99%
475,604 $17.5 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $6 Million - $7.28 Million
-199,266 Reduced 43.66%
257,098 $8.41 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $9,514 - $13,594
-352 Reduced 0.08%
456,364 $14.9 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $870,273 - $987,648
26,436 Added 6.14%
456,716 $17.9 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $4.22 Million - $5.48 Million
129,968 Added 43.28%
430,280 $15.5 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $648,777 - $728,426
17,544 Added 6.2%
300,312 $13 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $309,600 - $340,147
8,256 Added 3.01%
282,768 $12 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $10.6 Million - $12 Million
274,512 New
274,512 $12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track O'Shares Investment Advisers, LLC Portfolio

Follow O'Shares Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shares Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shares Investment Advisers, LLC with notifications on news.